NUVB – nuvation bio inc. class a (US:NASDAQ)
Stock Stats
News
Nuvation Bio (NUVB) Bounces Back 12% on Impressive Clinical Trial Result [Yahoo! Finance]
Lenz Therapeutics: A Close Look [Seeking Alpha]
Nuvation Bio Inc. (NUVB) Presents at Citi Annual Global Healthcare Conference 2025 Transcript [Seeking Alpha]
Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology
Nuvation Bio (NYSE:NUVB) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Form 4 Nuvation Bio Inc. For: Dec 01 Filed by: Liu Dongfang
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
Form 4 Nuvation Bio Inc. For: Nov 25 Filed by: Liu Dongfang
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
Form 8-K Nuvation Bio Inc. For: Nov 26
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.